Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fetal transfusion therapy

D W Skupski1, C F Wolf, J B Bussel

  • 1Department of Ob-Gyn, New York Hospital-Cornell Medical Center, NY 10021, USA.

Obstetrical & Gynecological Survey
|March 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased risk of haematological malignancy in adults over age 60 with thrombocytopenia compared with matched controls: Time for an upfront bone marrow evaluation?

British journal of haematology·2024
Same author

Evaluation of classic and novel ultrasound signs of placenta accreta spectrum.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2021
Same author

The vaginal microbiome in pregnant women: knowledge gaps in relation to clinical relevance.

BJOG : an international journal of obstetrics and gynaecology·2020
Same author

Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study.

BJOG : an international journal of obstetrics and gynaecology·2020
Same author

Alphabet soup.

BJOG : an international journal of obstetrics and gynaecology·2020
Same author

Abandon ship?

BJOG : an international journal of obstetrics and gynaecology·2020
Same journal

Amniotic Fluid Embolism: A Silent Threat to Maternal Life- An Up-to-Date Comprehensive Review of the Pathophysiology, Diagnosis, and Outcome.

Obstetrical & gynecological survey·2026
Same journal

A System Review of Pathophysiology, Diagnosis, and Clinical Management of Intrauterine Adhesions.

Obstetrical & gynecological survey·2026
Same journal

Atrial Fibrillation and Atrial Flutter in Pregnancy: Epidemiology, Pathophysiology, and Management.

Obstetrical & gynecological survey·2026
Same journal

Heavy Menstrual Bleeding in the Gynecology Clinic: A Call for Awareness and Standardized Screening for Underlying Bleeding Disorders.

Obstetrical & gynecological survey·2026
Same journal

Uterine Sarcomas: Clinical Management and a Review of Systemic Therapy.

Obstetrical & gynecological survey·2026
Same journal

Female Sexual Dysfunction: Current Models and Treatment Options.

Obstetrical & gynecological survey·2026
See all related articles

Advances in fetal cytopenia diagnosis and treatment are rapidly evolving. New techniques improve monitoring, intrauterine transfusions, and genetic testing for better outcomes in alloimmunized pregnancies.

Area of Science:

  • Perinatology
  • Fetal Medicine
  • Hematology

Background:

  • Fetal cytopenias, including red blood cell and platelet deficiencies, pose significant risks during pregnancy.
  • Alloimmunization in pregnancy requires careful monitoring and timely intervention to prevent severe fetal complications.

Purpose of the Study:

  • To review recent advancements in the diagnosis and management of fetal red blood cell and platelet cytopenias.
  • To outline current strategies for monitoring, invasive procedures, and intrauterine transfusion therapies.

Main Methods:

  • Review of noninvasive monitoring techniques and invasive procedures like amniocentesis and cordocentesis.
  • Discussion of intrauterine transfusion therapy for red blood cells and platelets.
  • Integration of advances in ultrasound, blood banking, and genetic engineering.

Related Experiment Videos

Main Results:

  • Refined noninvasive and invasive methods enable prompt recognition and treatment of fetal cytopenias.
  • Polymerase chain reaction (PCR) for fetal Rh(D) genotyping offers early diagnostic capabilities.
  • Specialized centers have developed extensive experience in managing severely affected fetuses.

Conclusions:

  • Current diagnostic and therapeutic strategies are improving outcomes for fetuses with cytopenias.
  • Emerging technologies like hematopoietic stem cell transplantation and gene therapy hold future promise for prevention and treatment.